Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kerkhofs, TMA"'
Autor:
Hermsen, IGC, Haak, HR, de Krijger, Ronald, Kerkhofs, TMA, Feelders, R.A., de Herder, W.W., Wilmink, H, Smit, JWA, Gelderblom, H, de Miranda, NFCC, van Eijk, R (Ronald), van Eijk, R, van Wezel, T, Morreau, H
Publikováno v:
European Journal of Endocrinology, 169, 51-8
European Journal of Endocrinology, 169(1), 51-58. Bioscientifica Ltd
European Journal of Endocrinology, 169(1), 51-58
European journal of endocrinology / European Federation of Endocrine Societies, 169(1), 51-58. BioScientifica Ltd.
European Journal of Endocrinology, 169, 1, pp. 51-8
European Journal of Endocrinology, 169(1), 51-58. Bioscientifica Ltd
European Journal of Endocrinology, 169(1), 51-58
European journal of endocrinology / European Federation of Endocrine Societies, 169(1), 51-58. BioScientifica Ltd.
European Journal of Endocrinology, 169, 1, pp. 51-8
BackgroundAdrenocortical carcinoma (ACC) is a rare disease with a poor prognosis and limited therapeutic options. Mitotane is considered the standard first-line therapy with only 30% of the patients showing objective tumour response. Defining predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f60cc82f27326db43a7e2c04d1be841
https://hdl.handle.net/1887/100829
https://hdl.handle.net/1887/100829
Autor:
Poleé IN; Department of Pulmonology, Zuyderland Medical Center, Heerlen, the Netherlands., Hermans BCM; Department of Medical Oncology, Maxima Medical Center, Veldhoven, the Netherlands., van der Zwan JM; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands., Bouwense SAW; Department of Surgery, Maastricht University Medical Center, Maastricht, the Netherlands., Dercksen MW; Department of Medical Oncology, Maxima Medical Center, Veldhoven, the Netherlands., Eskens FALM; Department of Internal Medicine, Division of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands., Havekes B; Department of Internal Medicine, Division of Endocrinology, Maastricht University Medical Center, Maastricht, the Netherlands., Hofland J; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, the Netherlands., Kerkhofs TMA; Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Klümpen HJ; Department of Medical Oncology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands., Latten-Jansen LM; Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Speel EM; Department of Pathology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., Verburg FA; Department of Radiology&Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands., Walenkamp AME; Department of Internal Medicine, Division of Medical Oncology, University Medical Center Groningen, Groningen, the Netherlands., Geurts SME; Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands., de Vos-Geelen J; Department of Internal Medicine, Division of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. Electronic address: judith.de.vos@mumc.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Sep; Vol. 172, pp. 252-263. Date of Electronic Publication: 2022 Jul 06.
Autor:
Steenaard RV; Department of Internal Medicine, Máxima MC, 5631 BM Eindhoven/Veldhoven, The Netherlands.; CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht University, 6229 HX Maastricht, The Netherlands.; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands., Kerkhofs TMA; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands., Zijlstra M; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.; Department of Internal Medicine, St. Jans Gasthuis, 6001 BE Weert, The Netherlands.; Netherlands Association for Palliative Care (PZNL), 3511 DT Utrecht, The Netherlands., Mols F; Department of Research, Netherlands Comprehensive Cancer Organization (IKNL), 3511 DT Utrecht, The Netherlands.; Department of Medical and Clinical Psychology, Tilburg University, 5037 AB Tilburg, The Netherlands., Kerstens MN; Department of Internal Medicine, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands., Timmers HJLM; Department of Internal Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands., Dreijerink KMA; Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, 1081 HV Amsterdam, The Netherlands., Eekhoff EMW; Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, 1081 HV Amsterdam, The Netherlands., Nieveen van Dijkum EJM; Department of Surgery, Cancer Center Amsterdam, Amsterdam University Medical Centers, 1081 HV Amsterdam, The Netherlands., Corssmit EPM; Department of Endocrinology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Kremers MNT; CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht University, 6229 HX Maastricht, The Netherlands.; Department of Internal Medicine, St. Jans Gasthuis, 6001 BE Weert, The Netherlands., Feelders RA; Department of Endocrinology, Erasmus Medical Center, 3015 CA Rotterdam, The Netherlands., Haak HR; Department of Internal Medicine, Máxima MC, 5631 BM Eindhoven/Veldhoven, The Netherlands.; CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht University, 6229 HX Maastricht, The Netherlands.; Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Center+, 6229 HX Maastricht, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Mar 08; Vol. 14 (6). Date of Electronic Publication: 2022 Mar 08.
Autor:
Steenaard RV; Department of Internal Medicine, Máxima MC, Veldhoven, Eindhoven, The Netherlands.; Maastricht University, CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, The Netherlands., Ettaieb MHT; Department of Internal Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands., Kerkhofs TMA; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Centre+, Maastricht, The Netherlands., Haak HR; Department of Internal Medicine, Máxima MC, Veldhoven, Eindhoven, The Netherlands.; Maastricht University, CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, The Netherlands.; Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
Publikováno v:
Expert opinion on drug metabolism & toxicology [Expert Opin Drug Metab Toxicol] 2021 Jun; Vol. 17 (6), pp. 677-683. Date of Electronic Publication: 2021 May 04.
Autor:
Yin A; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.; Leiden Network for Personalized Therapeutics, Leiden University Medical Center, Leiden, The Netherlands., Ettaieb MHT; Division of Endocrinology, Department of Internal Medicine, Máxima Medical Center, Eindhoven/Veldhoven, The Netherlands., Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.; Leiden Network for Personalized Therapeutics, Leiden University Medical Center, Leiden, The Netherlands., van Deun L; Division of Endocrinology, Department of Internal Medicine, Máxima Medical Center, Eindhoven/Veldhoven, The Netherlands., Kerkhofs TMA; Division of Medical Oncology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands., van der Straaten RJHM; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Corssmit EPM; Division of Endocrinology, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Kerstens MN; Department of Endocrinology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Feelders RA; Division of Endocrinology, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands., Eekhoff M; Division of Endocrinology, Department of Internal Medicine, Amsterdam University Medical Center, Location VUmc, Amsterdam, The Netherlands., Timmers HJLM; Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., D'Avolio A; Department of Medical Sciences, Unit of Infectious Diseases, Amedeo di Savoia Hospital, University of Turin, Turin, Italy., Cusato J; Department of Medical Sciences, Unit of Infectious Diseases, Amedeo di Savoia Hospital, University of Turin, Turin, Italy., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.; Leiden Network for Personalized Therapeutics, Leiden University Medical Center, Leiden, The Netherlands., Haak HR; Division of Endocrinology, Department of Internal Medicine, Máxima Medical Center, Eindhoven/Veldhoven, The Netherlands.; Division of General Internal Medicine, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.; CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, The Netherlands., Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. D.J.A.R.Moes@lumc.nl.; Leiden Network for Personalized Therapeutics, Leiden University Medical Center, Leiden, The Netherlands. D.J.A.R.Moes@lumc.nl.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2021 Jan; Vol. 60 (1), pp. 89-102.